“Gemcitabine as a Therapeutic Alternative during Shortage of BCG: The CHLC (Hospital S. José) Experience”, APU Jour, vol. 36, no. 1-2, pp. 11–16, Sep. 2019, doi: 10.24915/aup.36.1-2.90.